What is the official website of Apotex Inc. ?

The official website of Apotex Inc. is http://www.apotex.com/.

What is Apotex Inc.'s cybersecurity risk score?

Apotex Inc. has an AI-generated cybersecurity risk score of 774 out of 1000, indicating a Fair security posture according to Rankiteo's assessment.

How many security incidents has Apotex Inc. experienced?

According to Rankiteo, Apotex Inc. currently holds 0 security badges, indicating that no recognized compliance certifications are currently verified for the organization.

Has Apotex Inc. been affected by any supply chain cyber incidents ?

According to Rankiteo, Apotex Inc. has not been affected by any supply chain cyber incidents, and no incident IDs are currently listed for the organization.

Does Apotex Inc. have SOC 2 Type 1 certification ?

According to Rankiteo, Apotex Inc. is not certified under SOC 2 Type 1.

Does Apotex Inc. have SOC 2 Type 2 certification ?

According to Rankiteo, Apotex Inc. does not hold a SOC 2 Type 2 certification.

Does Apotex Inc. comply with GDPR ?

According to Rankiteo, Apotex Inc. is not listed as GDPR compliant.

Does Apotex Inc. have PCI DSS certification ?

According to Rankiteo, Apotex Inc. does not currently maintain PCI DSS compliance.

Does Apotex Inc. comply with HIPAA ?

According to Rankiteo, Apotex Inc. is not compliant with HIPAA regulations.

Does Apotex Inc. have ISO 27001 certification ?

According to Rankiteo,Apotex Inc. is not certified under ISO 27001, indicating the absence of a formally recognized information security management framework.

Which industry does Apotex Inc. operate in ?

Apotex Inc. operates primarily in the Pharmaceutical Manufacturing industry.

How many employees does Apotex Inc. have ?

Apotex Inc. employs approximately 6,227 people worldwide.

Does Apotex Inc. own any subsidiaries ?

Apotex Inc. presently has no subsidiaries across any sectors.

How many LinkedIn followers does Apotex Inc. have ?

Apotex Inc.'s official LinkedIn profile has approximately 241,371 followers.

What is the NAICS classification code for Apotex Inc. ?

Apotex Inc. is classified under the NAICS code 3254, which corresponds to Pharmaceutical and Medicine Manufacturing.

Does Apotex Inc. have a Crunchbase profile ?

Yes, Apotex Inc. has an official profile on Crunchbase, which can be accessed here: https://www.crunchbase.com/organization/apotex-inc.

Does Apotex Inc. have a LinkedIn profile ?

Yes, Apotex Inc. maintains an official LinkedIn profile, which is actively utilized for branding and talent engagement, which can be accessed here: https://www.linkedin.com/company/apotex-inc-.

How many cybersecurity incidents has Apotex Inc. experienced ?

As of August 22, 2026, Rankiteo reports that Apotex Inc. has experienced 1 cybersecurity incidents.

How many peer or competitor companies does Apotex Inc. have ?

Apotex Inc. has an estimated 5,730 peer or competitor companies worldwide.

What types of cybersecurity incidents has Apotex Inc. faced ?

Incident Types: The types of cybersecurity incidents that have occurred include Ransomware.

NEWRankiteo Cyber Underwriting Desktop - Score, price, and bind from your desktop

WindowsmacOSLinux

Download

Badge your company to reduce your risk score and your cyber insurance costs!

Link verified badges to your company page to build trust with insurers and customers.

Apply now and get your badge!

Internal validation & live display

Insurers and partners see a safer profile

Faster underwriting decisions

Trusted by insurers. Chosen by leaders.

Proud contributor to the Society of Actuaries.

Apotex Inc.

Boost Score +25 with badge (5 left)

774

/1000

Fair

799

/1000

Fair

Apotex Inc. Vendor Cyber Rating & Cyber Score

apotex.com

cb in

Add Your Compliance Badge

Apotex Inc. is a proudly Canadian, global pharmaceutical company that produces high-quality, affordable medicines for patients around the world. Apotex employs almost 8,000 people worldwide in manufacturing, R&D, and commercial operations. Apotex Inc. exports to more than 100 countries and territories and operates in more than 45 countries, with a significant presence in Canada, the US, Mexico, and India. Through vertical integration, Apotex is comprised of multiple divisions and affiliates including Apotex Inc., focused on generics; Apobiologix, a division of Apotex Inc. focused on biosimilar development; Apotex Consumer Products, a division of Apotex Inc. focused on brand name products; and Global Active Pharmaceutical Ingredients

Apotex Inc. A.I CyberSecurity Scoring

Scoring History

Apotex Inc.

Apotex Inc. CyberSecurity News & History

Past Incidents

Attack Types

Entity

Type

Severity

Impact

Seen

Blog Details

Supply Chain Source

Incident Details

View

Apotex Inc.

Ransomware

100

8/2021

SI-553072525

Loading…

A.I.

Apotex Inc. Company Scoring based on AI Models

Cyber Incidents Likelihood 3 - 6 - 9 months

Actual

Prediction

Incident Predictions locked

Access Monitoring Plan

A.I Risk Score Likelihood 3 - 6 - 9 months

Actual

Prediction A

Prediction B

Prediction C

Prediction D

A.I. Risk Score Predictions locked

Access Monitoring Plan

Loading…

Underwriter Stats for Apotex Inc.

Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)

No incidents recorded for Apotex Inc. in 2026.

Incidents vs All-Companies Average (This Year)

No incidents recorded for Apotex Inc. in 2026.

Incident Types Apotex Inc. vs Pharmaceutical Manufacturing Industry Avg (This Year)

No incidents recorded for Apotex Inc. in 2026.

Incident History - Apotex Inc. (X = Date, Y = Severity)

Loading…

SUBSIDIARY

Apotex Inc. Subsidiaries

Apotex Inc.

Pharmaceutical Manufacturing

Website: http://www.apotex.com/

Company Size: 6,227

Apotex Pharmachem Inc.Pharmaceutical Manufacturing

SK Capital PartnersFinancial Services

ArchromaChemical Manufacturing

Color Atlas by ArchromaTextilherstellung

HeubachChemical Manufacturing

SEQENSPharmaceutical Manufacturing

SEQENS Pharmaceutical SolutionsPharmaceutical Manufacturing

SEQENS Personal CarePersonal Care Product Manufacturing

VanDeMark Chemical IncChemical Manufacturing

CanlakChemical Manufacturing

GEON Performance SolutionsPlastics Manufacturing

Isolatek InternationalWholesale Building Materials

Tilley DistributionChemical Manufacturing

EcopolPackaging and Containers Manufacturing

Noramco™Pharmaceutical Manufacturing

Luxium SolutionsManufacturing

Lacerta Group, LLC.Packaging and Containers Manufacturing

DeltechChemical Manufacturing

INEOS CalabrianChemical Manufacturing

Woodstock Sterile SolutionsPharmaceutical Manufacturing

J&K IngredientsFood and Beverage Manufacturing

Foremark Performance ChemicalsChemical Manufacturing

Florachem CorporationChemical Manufacturing

TPC GroupChemical Manufacturing

Valtris Specialty ChemicalsChemical Manufacturing

ChamplorFood and Beverage Manufacturing

Ascend Performance MaterialsChemical Manufacturing

Acteev By AscendTextile Manufacturing

SI GroupChemical Manufacturing

Careers at SI GroupChemical Manufacturing

ApobiologixBiotechnology Research

Apotex Inc. - QuébecPharmaceutical Manufacturing

Loading…

Apotex Inc. Similar Companies

Novo Nordisk

cb novonordisk.com

We’re not your typical healthcare company. In a modern world of quick fixes, we focus on solutions to defeat serious chronic disease and create long-term health. We seek out new ideas and put people first as we push the boundaries of science, make healthcare more accessible, and work to treat, prevent, and even cure diseases that affect millions of lives. Founded in Denmark in 1923, today we employ more than 68,800 people in 80 offices around the world – all united by our bold purpose to drive change to defeat serious chronic diseases. Want to learn more? Visit www.novonordisk.com. This page isn’t intended for discussions about products. As such, postings or comments that contain product discussions may be removed. This page is for discussions about Novo Nordisk and its subsidiaries and the initiatives and projects we are involved in. While we welcome everyone to make comments, we reserve the right to block and remove those that are off-topic, abusive or intended to spam. Any questions specific to products should be made to your healthcare professional. If you wish to file an adverse drug reaction please contact Novo Nordisk’s office in the country you live in: https://www.novonordisk.com/contact-us/find-local-information.html For other customer complaints, please contact us here: https://www.novonordisk.com/contact-us.html Please keep in mind that Novo Nordisk A/S and its subsidiaries work within a highly regulated industry. Therefore, comments that pertain to legal matters or regulatory issues may be removed. Comments contained on this site come from members of the public, and do not necessarily reflect the views of Novo Nordisk A/S. Novo Nordisk A/S does not endorse or approve any content added by other LinkedIn users. Learn more about our privacy disclaimer and community guidelines here: https://www.novonordisk.com/data-privacy-and-user-rights/social-media-privacy-disclaimer.html

MSD

msd.com

At MSD, known as Merck & Co., Inc., Rahway, NJ, USA in the United States and Canada, we are unified around our purpose: We use the power of leading-edge science to save and improve lives around the world. For more than 130 years, we have brought hope to humanity through the development of important medicines and vaccines. We aspire to be the premier research-intensive biopharmaceutical company in the world – and today, we are at the forefront of research to deliver innovative health solutions that advance the prevention and treatment of diseases in people and animals. We foster a diverse and inclusive global workforce and operate responsibly every day to enable a safe, sustainable and healthy future for all people and communities. For more information, visit www.msd.com and connect with us on Facebook, Instagram, Twitter, and YouTube.

MANKIND PHARMA LTD

mankindpharma.com

Mankind Pharma, one of the top 5 leading pharmaceutical companies in India, started its journey in 1995. Today, we have an employee base of over 20,000 and are racing towards $1 Billion. At Mankind, we aspire to aid the community in leading a healthy life by formulating, developing, commercializing, and delivering affordable and accessible medicines that satisfy urgent medical needs. We take great pride in the success of our products ranging from Pharma, OTC and FMCG brands like Manforce Condoms, Manforce Tablets, Manforce Staylong Gel, Unwanted 72, Prega News, Gas-O-Fast, Kaloree 1, Kabzend, Acne Star Gel and many others. Our operations are in 34 overseas destinations across Asia, Africa, South-East Asia, Gulf countries and CIS countries. Our Vision - To be a global pharmaceutical company, most admired for its Affordability, Quality and Accessibility of products. Our Mission - To be able to provide cost-effective, innovation based superior quality pharmaceutical products across the globe, to improve the lives of the patients. Mankind strongly believes and follows its Core Values: 𝐂𝐮𝐬𝐭𝐨𝐦𝐞𝐫 𝐂𝐞𝐧𝐭𝐫𝐢𝐜𝐢𝐭𝐲: Commitment to Customer - Internal and External 𝐐𝐮𝐚𝐥𝐢𝐭𝐲: It is in our DNA to maintain and deliver highest quality standards and products 𝐈𝐧𝐧𝐨𝐯𝐚𝐭𝐢𝐨𝐧: Intensely Research driven organization aiming at product innovation and technology improvements 𝐈𝐧𝐭𝐞𝐠𝐫𝐢𝐭𝐲: Always trustworthy, widely respected to be honest, and believed by everyone 𝐆𝐨 𝐁𝐞𝐲𝐨𝐧𝐝: Aim higher than capabilities 𝐏𝐞𝐨𝐩𝐥𝐞 𝐃𝐞𝐯𝐞𝐥𝐨𝐩𝐦𝐞𝐧𝐭 𝐚𝐧𝐝 𝐂𝐨𝐥𝐥𝐚𝐛𝐨𝐫𝐚𝐭𝐢𝐨𝐧: Together we are foreseeing future and diligently stimulating our people in attaining goals

Alembic Pharmaceuticals Limited

alembic-india.com

Established in 1907, Alembic Pharmaceuticals Limited is a leading pharmaceutical company in India. The Company is vertically integrated with the ability to develop, manufacture and market pharmaceutical products, pharmaceutical substances and Intermediates. Alembic is the market leader in the Macrolides segment of anti-infective drugs in India. Alembic's manufacturing facilities are located in Vadodara and Baddi in Himachal Pradesh. The plant at Vadodara has the largest fermentation capacity in India. The Panelav facility houses the API and formulation manufacturing (both US FDA approved) plants. The plant at Baddi, Himachal Pradesh manufactures formulations for the domestic and non-regulated export market. The company has a state of the art Research Centre at Vadodara.

Sanofi

sanofi.com

We are an R&D driven, AI-powered biopharma company committed to improving people’s lives and delivering compelling growth. We apply our deep understanding of the immune system to invent medicines and vaccines that treat and protect millions of people around the world, with an innovative pipeline that could benefit millions more. Our team is guided by one purpose: we chase the miracles of science to improve people’s lives; this inspires us to drive progress and deliver positive impact for our people and the communities we serve, by addressing the most urgent healthcare, environmental, and societal challenges of our time. Interactions with this account must comply with the Terms: https://bit.ly/sanofi-terms

MACLEODS PHARMACEUTICALS LTD.

macleodspharma.com

A vertically integrated, Global Pharmaceutical Company. Established in 1989, we are engaged in developing, manufacturing, and marketing a wide range of formulations across several major therapeutic areas including anti-infectives, cardiovascular, anti-diabetic, dermatology, and hormone treatment. We develop, manufacture, and globally distribute a broad range of pharmaceutical products across therapies in multiple dosage forms such as solid orals, liquid orals, topical formulations, injectables (Dry Powder) metered dose inhalers and dry powder inhalers. Our Vision To be a leading global pharmaceutical company by providing high quality, affordable and innovative therapeutic solutions for patients with diverse medical needs. Our Mission To contribute towards improving patients’ quality of life across the globe, by providing effective and accessible medicines.

Glenmark Pharmaceuticals

glenmarkpharma.com

Glenmark Pharmaceuticals Limited is a research-led, global organization committed to enriching lives. Innovation is deeply embedded in Glenmark’s culture; it is how we differentiate ourselves in our key markets and create greater value for our stakeholders. In our journey of innovation over the past four and a half decades, we have evolved from a generics company to a global organization offering specialty and branded products. Glenmark’s core values of Achievement, Respect, and Knowledge impart a sense of organizational unity that drives our growth. We have established a robust global branded generics, specialty, and OTC business; with a significant presence in the therapy areas of dermatology, respiratory, and oncology. Our ten state-of-the-art manufacturing facilities spread across four continents with operations in over 80 countries help us impact millions of patients across the globe. We recently consolidated our innovation efforts in small molecules and biologics research with the formation of ‘Ichnos Glenmark Innovation’ (IGI). This alliance is aimed at leveraging the capabilities of Glenmark and its subsidiary, Ichnos Sciences, to accelerate innovation in cancer treatment. To know more about IGI, check out: https://iginnovate.com/ Sustainability is an integral aspect of all our operations and we are focused on achieving our Environment, Social and Governance (ESG) goals. Our responsibility also extends to our communities, and over the years, our CSR efforts have touched the lives of over 3 million people.

Viatris

viatris.com

Viatris Inc. (NASDAQ: VTRS) is a global healthcare company uniquely positioned to bridge the traditional divide between generics and brands, combining the best of both to more holistically address healthcare needs globally. With a mission to empower people worldwide to live healthier at every stage of life, we provide access at scale. In 2022 alone, we supplied high-quality medicines to approximately 1 billion patients around the world. With our exceptionally extensive and diverse portfolio of medicines, a one-of-a-kind global supply chain designed to reach more people when and where they need them, and the scientific expertise to address some of the world’s most enduring health challenges, access takes on deep meaning at Viatris. We have the ability to touch all of life’s moments, from birth to end of life, acute conditions to chronic diseases. We are headquartered in the U.S., with global centers in Pittsburgh, Shanghai and Hyderabad, India Social Media Guidelines: https://newsroom.viatris.com/social-media-community-guidelines Investors: https://investor.viatris.com Corporate Social Responsibility: https://www.viatris.com/sustainability Connect with Viatris Instagram: https://www.instagram.com/viatrisinc X: https://www.x.com/viatrisinc Viatris and our recruiting firms will not ask for sensitive personal information, such as your social security number, date of birth or bank account details via text, email or social media. Additionally, Viatris representatives do not request payment or personal bank information nor send payment to purchase hardware on your own. Viatris.com is the primary source of all company job postings and authorized third-party career websites.

Zydus Group

zyduslife.com

The Zydus Group with an overarching purpose of empowering people with freedom to live healthier and more fulfilled lives, is an innovative, global life-sciences company that discovers, develops, manufactures, and markets a broad range of healthcare therapies. The group employs over 27000 people worldwide and is driven by its mission to unlock new possibilities in life-sciences through quality healthcare solutions that impact lives. The group aspires to transform lives through pathbreaking discoveries.

Loading…

NEWS

Apotex Inc. CyberSecurity News

Latest updates, reports, and threat intel affecting the global network.

January 09, 2025 08:00 AM

Exclusive: Ransomware gang claims responsibility for August hack of DBG Health

Newcomer Morpheus says it was behind an August 2024 compromise of an Australian pharmaceuticals and healthcare firm, posting employee passport scans to the...

Read Article

Loading…

CVE

Latest

Global CVEs (Not Company-Specific)

CVE-2026-53541

SUMMARY

OliveTin gives access to predefined shell commands from a web interface. The `filterToDefinedArgumentsOnly` function in the executor is intended to discard any arguments not explicitly defined in the action's configuration. However, prior to commit ebffd9f040f791208aee1db2e5a8aecd1e3e603d, a special case allows any argument whose name starts with `ot_` to bypass this filter. While two system arguments (`ot_executionTrackingId` and `ot_username`) are injected by OliveTin and overridden, all other `ot_`-prefixed arguments supplied by the user pass through unmodified. These bypassed arguments are not type-checked — the validation loop only iterates over the action's defined arguments, so `ot_`-prefixed arguments skip all type safety checks entirely; set as environment variables — via `buildEnv()`, with completely unvalidated values, and passed to the executed command; and included in the template context — available as `.Arguments.ot_*` in template rendering. Commit ebffd9f040f791208aee1db2e5a8aecd1e3e603d contains a patch.

Published

Date2026-08-21

Updated

Date2026-08-21

RISK INFORMATION (Score: 4.3)

cvss3

Base Score: 4.3

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:N/I:L/A:N

Impact Score

1.4

Exploitability

2.8

REFERENCES

CVE-2026-53525

SUMMARY

WeeChat (Wee Enhanced Environment for Chat) is a free chat client. In versions 0.3.1 through 4.9.0, the WeeChat relay authentication uses non-constant-time string comparison functions (weechat_strcasecmp and strcmp) to verify password hashes and plaintext passwords. An attacker can exploit timing differences to extract the server-computed hash character by character, then authenticate using the correct hash without knowing the password. Version 4.9.1 fixes the issue.

Published

Date2026-08-21

Updated

Date2026-08-21

RISK INFORMATION (Score: 7.4)

cvss3

Base Score: 7.4

Complexity: HIGH

CVSS:3.1/AV:N/AC:H/PR:N/UI:N/S:U/C:N/I:H/A:H

Impact Score

5.2

Exploitability

2.2

REFERENCES

https://github.com/weechat/weechat/security/advisories/GHSA-vhv8-g2r9-cwcc

CVE-2026-53524

SUMMARY

WeeChat (Wee Enhanced Environment for Chat) is a free chat client. In versions 4.3.0 through 4.9.0, the WeeChat relay module's WebSocket permessage-deflate decompression function relay_websocket_inflate() has no upper bound on output size. An authenticated relay user can send a small compressed WebSocket frame (~100 bytes) that decompresses to gigabytes, exhausting all server memory and crashing the entire WeeChat process. The api protocol enables permessage-deflate and requires authentication before WebSocket upgrade. Version 4.9.1 patches the issue.

Published

Date2026-08-21

Updated

Date2026-08-21

RISK INFORMATION (Score: 6.5)

cvss3

Base Score: 6.5

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:N/I:N/A:H

Impact Score

3.6

Exploitability

2.8

REFERENCES

https://github.com/weechat/weechat/security/advisories/GHSA-v2v4-45wm-5cr3

CVE-2026-53499

SUMMARY

FORT Validator is a Resource Public Key Infrastructure (RPKI) relying-party validator that produces validated route-origin data. FORT Validator versions through 1.6.7 contain an origin-validation error in their RRDP processing: a delegated CA under the same Trust Anchor Locator (TAL) can reference a victim CA’s public RRDP notification and snapshot URLs, causing FORT’s URL-based download cache to report success after deleting the victim’s local snapshot. Following a routine victim publication, this can silently remove the victim’s VRPs and other signed objects from FORT’s output, potentially enabling route hijacking or loss of reachability. Version 1.6.8 contains a patch that rejects cross-origin RRDP snapshot and delta URLs; as a workaround, administrators can disable HTTP/RRDP with --http.enabled=false while keeping rsync enabled, although this can leave data unavailable or stale where rsync is not supported.

Published

Date2026-08-21

Updated

Date2026-08-21

RISK INFORMATION (Score: )

cvss4

Base Score: 7.2

Complexity: LOW

CVSS:4.0/AV:N/AC:L/AT:P/PR:L/UI:N/VC:N/VI:H/VA:L/SC:N/SI:H/SA:H/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

Exploitability

REFERENCES

https://github.com/NICMx/FORT-validator/security/advisories/GHSA-qfm3-577x-rh54

CVE-2026-49360

SUMMARY

Recce is a data-validation toolkit for enhanced dbt (data build tool) PR review. Prior to version 1.50.0, OSS server deployments that expose the server to an untrusted network without authentication are vulnerable to unauthenticated SQL execution through the query run API. When Recce is configured with a DuckDB-backed project, an attacker can use DuckDB filesystem primitives to read and write files accessible to the Recce server process. The impact depends on how Recce is deployed, but may include disclosure of local files, tampering with Recce/dbt artifacts, modification of browser-served static files leading to stored XSS, and modification of application files if those paths are writable. If Recce is run as root, file access occurs with root privileges inside that host or container. This issue has been patched in Recce `v1.50.0`. Users should upgrade to Recce `v1.50.0` or later. The patch restricts unsafe file read/write behavior for DuckDB-backed query execution and hardens the affected query path. Other warehouse adapters have also been reviewed for similar exposure. Users who cannot upgrade immediately should avoid exposing `recce server` to the public internet or any untrusted network. Recommended mitigations include enabling authentication or placing Recce behind an authenticated reverse proxy/VPN, running Recce as a non-root user, using a read-only application filesystem where possible, and ensuring that sensitive files or credentials are not available to the Recce process.

Published

Date2026-08-21

Updated

Date2026-08-21

RISK INFORMATION (Score: )

cvss4

Base Score: 7.8

Complexity: LOW

CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:N/VC:L/VI:L/VA:L/SC:L/SI:H/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

Exploitability

REFERENCES

Loading…

API

Access Data Using Our API

Get company history

curl -i -X GET 'https://api.rankiteo.com/underwriter-getcompany-history?
linkedin_id=axa' -H 'apikey: YOUR_API_KEY_HERE'

Try It API Documentation Rapid

MEASURE

What Do We Measure ?

Incident

Finding

Grade

Digital Assets

Every week, Rankiteo analyzes billions of signals to give organizations a sharper, faster view of emerging risks. With deeper, more actionable intelligence at their fingertips, security teams can outpace threat actors, respond instantly to Zero-Day attacks, and dramatically shrink their risk exposure window.

These are some of the factors we use to calculate the overall score:

Network SecurityIdentify exposed access points, detect misconfigured SSL certificates, and uncover vulnerabilities across the network infrastructure.

SBOM (Software Bill of Materials)Gain visibility into the software components used within an organization to detect vulnerabilities, manage risk, and ensure supply chain security.

CMDB (Configuration Management Database)Monitor and manage all IT assets and their configurations to ensure accurate, real-time visibility across the company's technology environment.

Threat IntelligenceLeverage real-time insights on active threats, malware campaigns, and emerging vulnerabilities to proactively defend against evolving cyberattacks.

Rankiteo

By Rankiteo

★ ★ ★ ★ ★

View on G2.com

Rankiteo is a unified scoring and risk platform that analyzes billions of signals weekly to help organizations gain faster, more actionable insights into emerging threats. Empowering teams to outpace adversaries and reduce exposure.

View latest plans →View all security reports →

MILESTONEG

Users
Love Us

Loading…